Covid19

J&J Covid-19 Vaccine Recipients May Benefit More From Pfizer Or Moderna Boosters, Study Finds


People who received Johnson & Johnson’s Covid-19 vaccine may benefit more from a Moderna or Pfizer booster shot, preliminary data from a U.S. study showed on Wednesday, a finding that comes on the same day when the Food and Drug Administration raised some concerns about the trial data of J&J’s …

Read more @ www.forbes.com

Back to top button